Home » Topics » Regulatory

Regulatory
RSS

First oral contraceptive for heavy menstrual bleeding approved in U.S.

March 15, 2012

FDA approves first cell-based product made from allogeneic human cells and bovine collagen

March 14, 2012

FDA approves Surfaxin

March 7, 2012

First four-strain flu vaccine approved in U.S.

March 2, 2012

Esmya approved in Europe

Feb. 27, 2012

European Commission approves Glivec label update

Feb. 27, 2012

FDA grants first approval for drug-eluting coronary stent use in AMI

Feb. 23, 2012

BMS gains additional indication approvals for two anticancer drugs

Feb. 23, 2012

Line extension for Zyprexa approved in Japan

Feb. 23, 2012

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...